SPACInsider•3 days ago
Oncorus Incorporated is developing viral immunotherapies for cancer patients. The company's lead product candidate, ONCR-177 is in Phase I clinical trials for treating various cancers. ONCR-GBM is a preclinical oHSV program for treating brain cancer through intratumoral injection. Oncorus was incorporated in 2015 and is headquartered in Cambridge, MA.
What is Oncorus's quote symbol?
What is the 52 week high and low for Oncorus (NASDAQ: ONCR)?
How much is Oncorus stock worth today?
How much is Oncorus's stock price per share?
What is Oncorus's Market Cap?